143 related articles for article (PubMed ID: 34153574)
1. Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.
Li B; Zhang Z; Zhang JF; Liu J; Zuo XY; Chen F; Zhang GY; Fang HQ; Jin Z; Tang YZ
Eur J Med Chem; 2021 Nov; 223():113624. PubMed ID: 34153574
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker.
Jin Z; Wang L; Gao H; Zhou YH; Liu YH; Tang YZ
Eur J Med Chem; 2019 Nov; 181():111594. PubMed ID: 31419741
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker.
Zhang GY; Zhang Z; Li K; Liu J; Li B; Jin Z; Liu YH; Tang YZ
Bioorg Chem; 2020 Dec; 105():104398. PubMed ID: 33137559
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome.
Huang SY; Wang X; Shen DY; Chen F; Zhang GY; Zhang Z; Li K; Jin Z; Du D; Tang YZ
Bioorg Med Chem; 2021 May; 38():116138. PubMed ID: 33857737
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents.
Chai F; Wang J; Zhou KX; Wang SK; Liu YH; Jin Z; Tang YZ
Bioorg Chem; 2022 Sep; 126():105859. PubMed ID: 35605553
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents.
Zhang Z; Li K; Zhang GY; Tang YZ; Jin Z
Eur J Med Chem; 2020 Oct; 204():112604. PubMed ID: 32731187
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1
Wang J; Hu YH; Zhou KX; Wang W; Li F; Li K; Zhang GY; Tang YZ
Molecules; 2023 May; 28(9):. PubMed ID: 37175382
[TBL] [Abstract][Full Text] [Related]
8. Semisynthetic pleuromutilin antimicrobials with therapeutic potential against methicillin-resistant Staphylococcus aureus by targeting 50S ribosomal subunit.
Wang X; Wang R; Zhang ZS; Zhang GY; Jin Z; Shen R; Du D; Tang YZ
Eur J Med Chem; 2022 Jul; 237():114341. PubMed ID: 35430480
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker.
Liu J; Zhang GY; Zhang Z; Li B; Chai F; Wang Q; Zhou ZD; Xu LL; Wang SK; Jin Z; Tang YZ
Bioorg Chem; 2021 Jul; 112():104956. PubMed ID: 33991838
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents.
Zhang QW; Ren J; Lu JX; Chen XY; He XJ; Wang Q; Zhou ZD; Jin Z; Zeng ZL; Tang YZ
Drug Dev Res; 2023 Nov; 84(7):1437-1452. PubMed ID: 37534779
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection.
Fang HQ; Zeng J; Wang SK; Wang X; Chen F; Li B; Liu J; Jin Z; Liu YH; Tang YZ
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164203
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups.
Wang Q; Liu J; Zhou ZD; Zhou KX; Li F; Zhang QW; Wang SK; Wang W; Jin Z; Tang YZ
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):2078-2091. PubMed ID: 35875944
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and antibacterial activity of pleuromutilin derivatives.
Liu HX; Yao WY; Cui G; Zhou J; Yan H; Guo H; Wang YW; Zhang Y
Chem Biol Drug Des; 2024 Jun; 103(6):e14554. PubMed ID: 38806405
[TBL] [Abstract][Full Text] [Related]
14. Novel pleuromutilin derivatives with substituted 6-methylpyrimidine: Design, synthesis and antibacterial evaluation.
Fan Y; Liu Y; Wang H; Shi T; Cheng F; Hao B; Yi Y; Shang R
Eur J Med Chem; 2020 Dec; 207():112735. PubMed ID: 32827940
[TBL] [Abstract][Full Text] [Related]
15. A click chemistry approach to pleuromutilin derivatives, evaluation of anti-MRSA activity and elucidation of binding mode by surface plasmon resonance and molecular docking.
Zhang Z; Zhang ZS; Wang X; Xi GL; Jin Z; Tang YZ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):2087-2103. PubMed ID: 34823417
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of pleuromutilin derivatives containing 1,2,4-triazole linker.
Zhou ZD; Hu YH; Wang Q; Xu H; Xi GL; Liu Y; Gu L; Jin Z; Tang YZ
Drug Dev Res; 2023 Jun; 84(4):703-717. PubMed ID: 36896715
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker.
Gao ML; Zeng J; Fang X; Luo J; Jin Z; Liu YH; Tang YZ
Eur J Med Chem; 2017 Feb; 127():286-295. PubMed ID: 28068600
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial Activity of a Promising Antibacterial Agent: 22-(4-(2-(4-Nitrophenyl-piperazin-1-yl)-acetyl)-piperazin-1-yl)-22-deoxypleuromutilin.
Zuo XY; Gao H; Gao ML; Jin Z; Tang YZ
Molecules; 2021 Jun; 26(12):. PubMed ID: 34201372
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Antibacterial Activity, Toxicity and Resistance Analysis of Pleuromutilin Derivative Z33 against Methicillin-Resistant
Hu Y; Chen F; Zhou K; Zhang Z; Li F; Zhang J; Tang Y; Jin Z
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956888
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
Zhang Y; Xie C; Liu Y; Shang F; Shao R; Yu J; Wu C; Yao X; Liu D; Wang Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):764-775. PubMed ID: 33733986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]